Diabetic Foot Complications: Signs, Risks, and How to Prevent Them
When you have diabetes, even a small cut on your foot can turn into a major problem. This isn’t just a myth—it’s a real, well-documented risk. Diabetic foot complications, a group of serious conditions affecting the feet of people with diabetes, often starting with nerve damage and poor circulation. Also known as diabetic foot syndrome, these issues are the leading cause of non-traumatic lower limb amputations worldwide. The good news? Most of these problems are preventable with simple, daily habits.
Diabetic neuropathy, the nerve damage caused by high blood sugar over time is often the first step. You might not feel a blister, a pebble in your shoe, or a cut—until it’s infected. Then comes foot ulcers, open sores that don’t heal easily due to poor blood flow and weakened immune response. These aren’t just skin deep—they can reach bone and spread infection fast. Add in peripheral artery disease, when arteries narrow and reduce blood flow to the legs and feet, and you’ve got a dangerous mix. Without enough oxygen and nutrients, wounds can’t heal, and infections can turn deadly.
It’s not about fancy treatments or expensive creams. It’s about checking your feet every day, wearing proper shoes, controlling your blood sugar, and never ignoring a red spot or swelling. People who check their feet daily cut their risk of amputation by more than half. That’s not a guess—it’s what clinics and studies show. You don’t need to be a doctor to spot trouble. If your toe is numb, your skin is cracked, or a sore won’t close after a week, it’s time to act. The posts below cover real cases, practical steps, and what works when your feet are at risk. From how to choose the right socks to what antibiotics doctors actually prescribe for infected ulcers, you’ll find clear, no-fluff advice that helps you stay on your feet.
Canagliflozin Amputation Risk: What You Need to Know Now
Canagliflozin (INVOKANA) carries a real but manageable risk of foot amputations in people with diabetes. Learn who's most at risk, how to prevent complications, and why other SGLT2 inhibitors may be safer alternatives.